Avita Medical Signs Deal for Distribution in Malaysia

NORTHRIDGE, CA and PERTH, AUSTRALIA and
CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- Jun 07, 2016 -- Avita
Medical Limited (ASX: AVH) (OTCQX: AVMXY) has furthered its
expansion into the Asian market with the appointment of a
specialized wound care distributor for its products in
Malaysia.

The Company said it had concluded a deal with Mintcare, which
specialises in the distribution of wound care products throughout
the Asia-Pacific region. Avita Medical said Mintcare would first
focus on Malaysia in its marketing of Avita's regenerative medical
devices for burns, wounds and skin conditions. Mintcare has a
4-person sales force in the South-east Asian country, where
vitiligo alone is reported to affect an estimated 450,000
people(1), chronic wounds some 180,000(2) patients, and large burns
annually leave about 1,200(3) Malaysians hospitalized.

Avita Medical's ReCell® technology works through the rapid
delivery of viable cells harvested from a piece of the patient's
own skin and is administered by spraying the cells onto the
affected area to trigger healing. ReCell® will be launched at
an international wound care conference in Sabah, Malaysia in
August. Singapore-based Mintcare also has commercial presence in
Hong Kong, Indonesia, Philippines, Sri Lanka, Thailand, and
Vietnam, and its range includes wound care products that complement
Avita's offering.

"The addition of ReCell to the Mintcare product portfolio brings
great synergistic opportunities," said Mintcare Director Lamine
Guendil. "Mintcare has successfully developed a distribution
network in South East Asia specifically in the chronic wound care
field, primarily targeting diabetic foot ulcers and venous leg
ulcers with topical oxygen therapy. We're confident our many years
of experience in this industry and our in-depth knowledge of the
local environment and culture, will deliver success to ReCell®
in Malaysia."

Avita Medical's CEO, Adam Kelliher, said the deal in Malaysia
was another milestone in the Company's strategy to roll-out its
regenerative medical devices in key Asian markets. In recent
months, the Company has announced distribution agreements with
parties in China, Japan and South Korea, and it has been active in
Taiwan, where it donated devices following a mass casualty event
last summer in a waterpark that left some 500 people burned.

"The deal with Mintcare will give Avita Medical an active
presence to deliver our innovative treatments to Malaysia, a market
of 30 million people, and further underscores the significance of
the broader Asian healthcare market for our company," Kelliher
said. "We will keep developing our distributor network in the
region so that we are well-placed to address the significant
commercial opportunities in Avita."

ABOUT RECELL® AND RES™ReCell® is Avita
Medical's unique proprietary technology that enables a clinician to
rapidly create, at point of care in approximately 30 minutes,
Regenerative Epithelial Suspension (RES™) using a small
sample of the patient's skin. RES™ is an autologous
suspension comprising the cells and wound healing factors necessary
to regenerate natural, healthy skin. RES™ has a broad range
of applications and can be used to restart healing in unresponsive
wounds, to repair burns using less donor skin, yet with improved
functional and aesthetic outcomes, and to restore pigmentation and
improve cosmesis of damaged skin.

ABOUT AVITA MEDICAL LTDAvita Medical develops and
distributes regenerative products for the treatment of a broad
range of wounds, scars and skin defects. Avita's patented and
proprietary collection and application technology provides
innovative treatment solutions derived from a patient's own skin.
The company's lead product, ReCell®, is used in the treatment
of a wide variety of burns, plastic, reconstructive and cosmetic
procedures. ReCell® is patented, CE-marked for Europe,
TGA-registered in Australia, and CFDA-cleared in China. In the
United States, ReCell® is an investigational device limited by
federal law to investigational use. To learn more, visit www.avitamedical.com.

Contact Profile

NewsMaker

NewsMaker is an Australian Press Release Distribution and Social Media Marketing service founded in 2004. The company today represents over 22,000 brands who seek to share their content with journalists, bloggers and the community.